CN102784225A - Medicine for treating damp-heat type lumbar disc herniation - Google Patents
Medicine for treating damp-heat type lumbar disc herniation Download PDFInfo
- Publication number
- CN102784225A CN102784225A CN2012103179584A CN201210317958A CN102784225A CN 102784225 A CN102784225 A CN 102784225A CN 2012103179584 A CN2012103179584 A CN 2012103179584A CN 201210317958 A CN201210317958 A CN 201210317958A CN 102784225 A CN102784225 A CN 102784225A
- Authority
- CN
- China
- Prior art keywords
- medicine
- heat type
- damp
- radix
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating damp-heat type lumbar disc herniation, which is prepared by taking traditional Chinese medicines as raw materials. The traditional Chinese medicine is prepared by selecting and washing the raw materials, such as lumbricus, ground beeltle, scorpio, zaocys dhumnade, prepared pangolin scales, olibanum, myrrh, radix angelicae pubescentis, poria cocos, rhizoma atractylodis, radix stephaniae tetrandrae, radix paeoniae rubra, coxtex moutan and cortex phellodendri, uniformly mixing, grinding into medicinal powder, filling into capsules, and disinfecting and sterilizing to obtain capsule products. According to the invention, the medicine used for treating damp-heat type lumbar disc herniation has the characteristics of definite efficacy, rapidness, convenience, and low drug price, and is safe to take.
Description
Technical field
The present invention relates to a kind of medicine of treating prolapse of lumbar intervertebral disc, particularly relating to a kind of is the Chinese medicine of the treatment damp-heat type prolapse of lumbar intervertebral disc of crude drug preparation with Chinese medicine.
Background technology
Prolapse of lumbar intervertebral disc is a kind of commonly encountered diseases, is mainly between twenty and fifty people.Prolapse of lumbar intervertebral disc is that to break that the back outstanding pressuring neural root of vertebral pulp causes with the lumbago and skelalgia be the disease that mainly shows to fibrous ring.The symptoms of lower extremity that prolapse of lumbar intervertebral disc causes often with walk, stand relevant, the patient who has shows as the persistent ache fiber crops, severe symptom influences Ambulatory Activity, the severe patient lower extremity paralysis.
The method of treatment prolapse of lumbar intervertebral disc mainly contains operative treatment, interventional therapy, Western medicine at present.But these methods mainly are used for relief of symptoms, can not play the purpose of radical cure, and expensive, have side effect.
Summary of the invention
The purpose of this invention is to provide a kind of medicine of treating the damp-heat type prolapse of lumbar intervertebral disc, this medicine promoting the flow of QI in the collateral by warming the meridian, blood circulation promoting and blood stasis dispelling, expelling wind and dampness can play treating both the principal and secondary aspects of a disease to the treatment of damp-heat type prolapse of lumbar intervertebral disc, and drug effect is rapid, the purpose that therapeutic effect is good.
A kind of medicine of treating the damp-heat type prolapse of lumbar intervertebral disc is that crude drug prepares by the Chinese medicine of following portions by weight:
Pheretima 9～13 Eupolyphaga Seu Steleophagas 8～12 Scorpio 8～12
Zaocys 8～12 big gun Squama Manis 7～10 Olibanums 10～12
Myrrha 8～12 Radix Angelicae Pubescentiss 8～10 Poria 8～12
Rhizoma Atractylodis 6～10, Radix Stephaniae Tetrandrae 6～8 Radix Paeoniae Rubra 8～12
Cortex Moutan 8～12 Cortex Phellodendris 6～8.
Can said medicine be processed any dosage form on the pharmaceutics, like tablet, pill, powder, capsule etc., the preferred dosage form of the present invention is a capsule.
The concrete method for preparing of medicine of the present invention being processed capsule is:
Said medicine by said parts by weight mix homogeneously, is ground into 100～120 purpose medicated powder, and in incapsulating, sterilization makes the capsule product.
Damp-heat type shows as in the prolapse of lumbar intervertebral disc syndrome-classification: flank pain, and lower limb is soft unable, and sore spot is with hotness, and chance heat or rainy day increase bitterly, movable back alleviation of pain, aversion to heat is thirsty, oliguria with reddish urine.Yellow and greasy fur, soft and rapid pulse or stringy and rapid pulse are so the Therapeutic Principle of damp-heat type prolapse of lumbar intervertebral disc is because of promoting the flow of QI in the collateral by warming the meridian, blood circulation promoting and blood stasis dispelling, expelling wind and removing dampness.The Pheretima heat clearing away, spasmolytic; The Eupolyphaga Seu Steleophaga removing blood stasis, reunion of fractured tendons and bones; The Scorpio spasmolytic that relieves dizziness, high fever, infantile convulsions, epilepsy, etc., removing obstruction in the collateral to relieve pain; The Zaocys dispelling wind and removing obstruction in the collateral, arresting convulsion; It is active that the big gun Squama Manis is searched wind, the stimulating milk secretion of stimulating the menstrual flow; The Olibanum regulating qi and activating blood, analgesic therapy; The Myrrha promoting flow of QI and blood, subduing swelling and relieving pain; The Radix Angelicae Pubescentis expelling wind and removing dampness, numbness relieving and pain relieving; The Poria eliminating dampness and diuresis, invigorating the spleen and regulating the stomach; Rhizoma Atractylodis are drying damp and strengthening spleen, expelling wind and cold; The Radix Stephaniae Tetrandrae inducing diuresis to remove edema, wind-expelling pain-stopping; The Radix Paeoniae Rubra clearing away heat and cooling blood, eliminating stasis to stop pain; The Cortex Moutan clearing away heat and cooling blood; Promoting blood circulation to remove blood stasis; Cortex Phellodendri heat clearing and damp drying, pathogenic fire purging are removed and are steamed.All medicines share, and promoting the flow of QI in the collateral by warming the meridian, blood circulation promoting and blood stasis dispelling, wind prevailing over dampness are used for the treatment of damp-heat type prolapse of lumbar intervertebral disc, have curative effect really, rapidly, conveniently, and the medicine valency is cheap, takes safe characteristics.
For further investigating the clinical efficacy and the safety of medicine of the present invention, select 40 routine prolapse of lumbar intervertebral disc patients that the curative effect of medicine of the present invention has been carried out clinical observation.
All case all is diagnosed as the damp-heat type prolapse of lumbar intervertebral disc according to the diagnosis basis and the typing of " traditional Chinese medical science disease diagnosis criterion of therapeutical effect ".
Therapeutic Method
Adopt capsule medicine of the present invention to treat, take every day 2 times, each 4.
Criterion of therapeutical effect
Standard with reference to State Administration of Traditional Chinese Medicine's " traditional Chinese medical science disease diagnosis criterion of therapeutical effect " formulation.Recovery from illness: pain symptom disappears, and activity is followed up a case by regular visits to not recurrence in 1 year freely.Effectively: pain symptom alleviates, and still has sense of discomfort, follows up a case by regular visits to and does not increase the weight of in 1 year.Invalid: pain symptom and the preceding contrast of treatment no change.
Case treatment back efficacy result is seen table 1.
Curative effect relatively behind the table 1 40 routine patient treatments
| Group | The example number | Recovery from illness n (%) | Effective n (%) | Invalid n (%) | Total effective rate n (%) |
| The treatment group | 40 | 24（60） | 14（35） | 2（5） | 38（95） |
The specific embodiment
Embodiment 1
Get Pheretima 9g, Eupolyphaga Seu Steleophaga 8 g, Scorpio 8 g, Zaocys 8 g, big gun Squama Manis 7 g, Olibanum 10 g, Myrrha 8 g, Radix Angelicae Pubescentis 8 g, Poria 8 g, Rhizoma Atractylodis 6 g, Radix Stephaniae Tetrandrae 6 g, Radix Paeoniae Rubra 8 g, Cortex Moutan 8 g, Cortex Phellodendri 6 g mix homogeneously selected, that clear water is cleaned; Be ground into 120 purpose medicated powder; In incapsulating, sterilization makes the capsule product.
Embodiment 2
Get Pheretima 13g, Eupolyphaga Seu Steleophaga 12 g, Scorpio 12 g, Zaocys 12 g, big gun Squama Manis 10 g, Olibanum 12 g, Myrrha 12 g, Radix Angelicae Pubescentis 10 g, Poria 12 g, Rhizoma Atractylodis 10 g, Radix Stephaniae Tetrandrae 8 g, Radix Paeoniae Rubra 12 g, Cortex Moutan 12 g, Cortex Phellodendri 8 g mix homogeneously selected, that clear water is cleaned; Be ground into 100 purpose medicated powder; In incapsulating, sterilization makes the capsule product.
Claims (2)
1. medicine of treating the damp-heat type prolapse of lumbar intervertebral disc is that crude drug prepares by the Chinese medicine of following portions by weight:
Pheretima 9～13 Eupolyphaga Seu Steleophagas 8～12 Scorpio 8～12
Zaocys 8～12 big gun Squama Manis 7～10 Olibanums 10～12
Myrrha 8～12 Radix Angelicae Pubescentiss 8～10 Poria 8～12
Rhizoma Atractylodis 6～10, Radix Stephaniae Tetrandrae 6～8 Radix Paeoniae Rubra 8～12
Cortex Moutan 8～12 Cortex Phellodendris 6～8.
2. the medicine of treatment damp-heat type prolapse of lumbar intervertebral disc according to claim 1 is characterized in that said medicine is processed capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103179584A CN102784225A (en) | 2012-08-31 | 2012-08-31 | Medicine for treating damp-heat type lumbar disc herniation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103179584A CN102784225A (en) | 2012-08-31 | 2012-08-31 | Medicine for treating damp-heat type lumbar disc herniation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102784225A true CN102784225A (en) | 2012-11-21 |
Family
ID=47149944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012103179584A Pending CN102784225A (en) | 2012-08-31 | 2012-08-31 | Medicine for treating damp-heat type lumbar disc herniation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102784225A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102247585A (en) * | 2010-05-20 | 2011-11-23 | 潘治宇 | Chinese medicinal composition for treating rheumatism, preparation thereof and preparation method thereof |
-
2012
- 2012-08-31 CN CN2012103179584A patent/CN102784225A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102247585A (en) * | 2010-05-20 | 2011-11-23 | 潘治宇 | Chinese medicinal composition for treating rheumatism, preparation thereof and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 赖祥林: "活血化瘀法在骨科的临床应用新进展", 《中国中医骨伤科杂志》, vol. 13, no. 02, 28 April 2005 (2005-04-28) * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102488869B (en) | Traditional Chinese medicinal external-use liniment for muscle and bone ache | |
| CN101919988B (en) | Medicine compound for curing rheumatism rheumatoid arthritis and preparation method thereof | |
| CN102166277B (en) | Waist healing pill | |
| CN103055278B (en) | Medicament for treating rheumatism | |
| CN102940865A (en) | Externally applied medicament for treating rheumatoid arthritis and hyperosteogeny and preparation method thereof | |
| CN104758659A (en) | Traditional Chinese medicine paste for treating muscle and bone diseases | |
| CN1970045B (en) | Externally applied Chinese medicine for treating cervical and lumbar spondylosis | |
| CN102441123A (en) | Medicine for treating rheumarthritis | |
| CN102247501A (en) | Medicine for treating soft tissue injury | |
| CN102188661B (en) | Traditional Chinese medicine for removing arthralgia and preparation method thereof | |
| CN103211886A (en) | Medicament for treating rheumatic arthritis | |
| CN101690768A (en) | Vein and artery relieving pills for impediment of sinew | |
| CN104800463A (en) | Plaster for orthopaedics | |
| CN101983652A (en) | Traditional Chinese medicine for treating scapulohumeral periarthritis | |
| CN102335246B (en) | Composition of Chinese medicinal herbs for treating bone spurs | |
| CN102406870A (en) | Medicament for treating rheumatic arthralgia | |
| CN107050242A (en) | Treat Chinese medicine composition, the preparation method and applications of acute soft tissue injury | |
| CN102038930A (en) | Medicament for treating protrusion of lumbar vertebral disc | |
| CN105560736A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN102784225A (en) | Medicine for treating damp-heat type lumbar disc herniation | |
| CN102178758A (en) | Medicament for treating peripheral nerve of diabetes | |
| CN103550620B (en) | A kind of externally-applied medicinal composition treating rheumatalgia | |
| CN103157011B (en) | Traditional Chinese medicine composite for promoting fracture healing | |
| CN100593409C (en) | Medicinal liquor for treating trigeminal neuralgia | |
| CN104547915A (en) | Traditional Chinese medicine composition for treating traumatic injury and medicinal liquor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20121121 |